We are pleased to confirm the latest addition to our Optimise suite of programmes - Cardiology: focus on triple therapy in practice.
According to the AF Association, one in four people will develop atrial fibrillation, which affects an estimated 1.5 million people in the UK.
People who undergo coronary artery stent placement and also have an indication for anticoagulation, such as atrial fibrillation, may be prescribed a number of medicines which are new to them, including triple therapy.
Pharmacy teams can empower patients by helping them to understand why the medicines are prescribed and the different durations.
Triple therapy in cardiology is a complex clinical situation where pharmacy teams can improve patient care.
This programme will help learners to understand how treatment is individualised to patients by weighing up risks and benefits.
Our Optimise programmes are intended to last up to one hour - approximately 20 minutes of preparation, and 40 minutes' small group learning.
So if you work in a clinical setting and wish to complete the learning with your colleagues, click here.